[Antifibrotic treatment]

Dtsch Med Wochenschr. 2014 Dec;139(49):2523-5. doi: 10.1055/s-0034-1387450. Epub 2014 Nov 25.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Cystine / adverse effects
  • Cystine / analogs & derivatives*
  • Cystine / therapeutic use
  • Drug Approval
  • Free Radical Scavengers / adverse effects
  • Free Radical Scavengers / therapeutic use*
  • Humans
  • Idiopathic Pulmonary Fibrosis / diagnosis
  • Idiopathic Pulmonary Fibrosis / drug therapy*
  • Idiopathic Pulmonary Fibrosis / mortality
  • Indoles / adverse effects
  • Indoles / therapeutic use*
  • Pyridones / adverse effects
  • Pyridones / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Survival Rate
  • Treatment Outcome
  • Vital Capacity / drug effects

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antineoplastic Agents
  • Free Radical Scavengers
  • Indoles
  • Pyridones
  • Cystine
  • pirfenidone
  • nintedanib
  • N-monoacetylcystine